Total Visits

Views
A prospective randomized phase III study in non-small-cell lung cancer comparing cisplatin, ifosfamide, vinblastine (VIP) versus cisplatin, ifosfamide and etoposide (VIP-16)89

Total Visits Per Month

January 2024February 2024March 2024April 2024May 2024June 2024July 2024
A prospective randomized phase III study in non-small-cell lung cancer comparing cisplatin, ifosfamide, vinblastine (VIP) versus cisplatin, ifosfamide and etoposide (VIP-16)1000310

Top country views

Views
Poland52
United States27
Sweden3
Ireland2
Japan2
Australia1
France1
India1

Top cities views

Views
Warsaw52
San Ramon6
Ann Arbor5
Boardman5
Dublin2
Stockholm2
Des Moines1
Fairfield1
Falls Church1
Louisville1